APA (7th ed.) Citation

Jagomäe, T., Seppa, K., Reimets, R., Pastak, M., Plaas, M., Hickey, M. A., . . . Plaas, M. (2021). Early Intervention and Lifelong Treatment with GLP1 Receptor Agonist Liraglutide in a Wolfram Syndrome Rat Model with an Emphasis on Visual Neurodegeneration, Sensorineural Hearing Loss and Diabetic Phenotype. MDPI AG.

Chicago Style (17th ed.) Citation

Jagomäe, Toomas, et al. Early Intervention and Lifelong Treatment with GLP1 Receptor Agonist Liraglutide in a Wolfram Syndrome Rat Model with an Emphasis on Visual Neurodegeneration, Sensorineural Hearing Loss and Diabetic Phenotype. MDPI AG, 2021.

MLA (8th ed.) Citation

Jagomäe, Toomas, et al. Early Intervention and Lifelong Treatment with GLP1 Receptor Agonist Liraglutide in a Wolfram Syndrome Rat Model with an Emphasis on Visual Neurodegeneration, Sensorineural Hearing Loss and Diabetic Phenotype. MDPI AG, 2021.